Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01772654 · ClinicalTrials.gov registry record · NA
Arterial Spin Labeling MRI Focal Abnormalities in Refractory Epilepsy
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 73
- Enrollment target
NCT01772654: Completed NA study, sponsored by Mayo Clinic.
NCT01772654 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01772654, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 73 participants
- Enrollment target
Study Summary
This study will evaluate a type of Magnetic Resonance Imaging (MRI) sequence called arterial spin labeling (ASL). The investigators hope that ASL can better localize areas of the brain (lesions) that cause epilepsy. This type of MRI does not require contrast, does not use any radiation, and adds on 4 minutes to the routine MRI that is done for patients with epilepsy. The study hypothesis is that in patients with refractory epilepsy, Arterial Spin Labeling (ASL) MRI will show areas of abnormality in the brain to the same degree as single-photon emission computerized tomography (SPECT) and positron emission tomography (PET) studies.
Interventions
- DEVICE Arterial Spin Labeled (ASL) MRI sequence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01772654
The ClinicalTrials.gov registry entry for NCT01772654 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Arterial Spin Labeled (ASL) MRI sequence is the first listed.
NCT01772654 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01772654 about?
NCT01772654 is a clinical study titled "Arterial Spin Labeling MRI Focal Abnormalities in Refractory Epilepsy". This study will evaluate a type of Magnetic Resonance Imaging (MRI) sequence called arterial spin labeling (ASL). The investigators hope that ASL can better localize areas of the brain (lesions) that cause epilepsy. This type of MRI does not require contrast, does not use any radiation, and adds on ...
What is the current status of trial NCT01772654?
This trial is currently completed. It is a NA study. The enrollment target is 73 participants. The study started on 2013-01. Estimated completion is 2013-11.
What interventions are being tested in trial NCT01772654?
The interventions under investigation include: Arterial Spin Labeled (ASL) MRI sequence (DEVICE).
Who is sponsoring clinical trial NCT01772654?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.